Depression and Anxiety Trial, Recruiting NCT07290543 Sponsor: Northwestern University Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT07290543
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For healthcare professionals and researchers (Aim 1):

  • People who have been personally invited by a member of the study team
  • People working in healthcare (such as doctors, nurses, or pharmacists), patient advocacy, healthcare or technology research, or healthcare administration and management
  • People aged 18 or older
  • People who speak English
  • People who are willing and able to give their informed consent to participate

For older cancer survivors living in rural areas (Aim 2):

  • People who live in a rural area, as defined by the Health Resources & Services Administration (HRSA) rural classification system
  • People who report having been diagnosed with any type of cancer
  • People who report having finished their main cancer treatment (such as surgery, chemotherapy, targeted therapy, or hormone therapy) aimed at curing the cancer
  • People who have access to a computer, smartphone, or tablet
  • People aged 65 or older
  • People whose screening results show a Cancer and Treatment Distress (CTXD) score above 0.85 (the trial site will assess this)
  • People who have a caregiver who is willing to take part in the study
  • People who are not living in an institution (such as a nursing home or care facility)
  • People who are sufficiently proficient in English to participate
  • People who are willing and able to give their informed consent to participate

For caregivers (Aim 2):

  • People who are an informal caregiver (such as a partner, child, or friend) of an eligible rural older cancer survivor participating in this trial — caregivers may live in a rural or urban area and do not need to live with the cancer survivor
  • People who have access to the internet
  • People aged 18 or older
  • People who are not living in an institution
  • People who are sufficiently proficient in English to participate
  • People who are willing and able to give their informed consent to participate

For the final workshop (Aim 3):

  • People working as healthcare providers, medical or practice managers, patient care coordinators, or medical health technologists

Who may not be able to join:

For older cancer survivors living in rural areas (Aim 2):

  • People whose cancer comes back, or who receive a new cancer diagnosis, while they are participating in the trial
  • People who are currently admitted as inpatients in a hospital or medical facility
  • People whose cognitive (thinking or memory) difficulties would prevent them from being able to give written informed consent

For caregivers (Aim 2):

  • People who are currently admitted as inpatients in a hospital or medical facility
  • People whose cognitive (thinking or memory) difficulties would prevent them from being able to give written informed consent

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Marquita W Lewis, PhD, Northwestern University

Phone: 312-503-1986

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
26 August 2025
Est. completion
26 August 2031

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Cancer Related Distress (validated 23-item scale)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov